Genomics

Dataset Information

0

Preclinical and first-in-human of Purinostat Mesylate, a novel selective HDAC I/IIb inhibitor, in relapsed or refractory multiple myeloma and lymphoma

ABSTRACT: Preclinical and first-in-human of Purinostat Mesylate, a novel selective HDAC I/IIb inhibitor, in relapsed or refractory multiple myeloma and lymphoma

PROVIDER: PRJNA1261787 | ENA |

REPOSITORIES: ENA

Json Xml

Dataset's files

Source:
Action DRS
SRR33556577_1.fastq.gz Fastqsanger.gz
SRR33556577_2.fastq.gz Fastqsanger.gz
SRR33556579_1.fastq.gz Fastqsanger.gz
SRR33556579_2.fastq.gz Fastqsanger.gz
SRR33556581_1.fastq.gz Fastqsanger.gz
Items per page:
1 - 5 of 18

Similar Datasets

Transcriptomics Preclinical and first-in-human of Purinostat Mesylate, a novel selective HDAC I/IIb inhibitor, in relapsed or refractory multiple myeloma and lymphoma
2025-05-15 | GSE296835 | GEO
Transcriptomics Preclinical and first-in-human of Purinostat Mesylate, a novel selective HDAC I/IIb inhibitor, in relapsed or refractory multiple myeloma and lymphoma [PDX]
2025-05-15 | GSE296833 | GEO
Transcriptomics Preclinical and first-in-human of Purinostat Mesylate, a novel selective HDAC I/IIb inhibitor, in relapsed or refractory multiple myeloma and lymphoma [scRNA-seq]
2025-05-23 | GSE297562 | GEO
Genomics Preclinical and first-in-human of Purinostat Mesylate, a novel selective HDAC I/IIb inhibitor, in relapsed or refractory multiple myeloma and lymphoma
| PRJNA1259464 | ENA
Genomics Preclinical and first-in-human of Purinostat Mesylate, a novel selective HDAC I/IIb inhibitor, in relapsed or refractory multiple myeloma and lymphoma [PDX]
| PRJNA1261791 | ENA
Genomics Preclinical and first-in-human of Purinostat Mesylate, a novel selective HDAC I/IIb inhibitor, in relapsed or refractory multiple myeloma and lymphoma [scRNA-seq]
| PRJNA1265191 | ENA
Genomics Genomic Analysis of Relapsed/Refractory DLBCL
| PRJNA1200817 | ENA
Genomics DNA methylation of Relapsed/Refractory AML
| PRJNA934390 | ENA
Genomics Genomic Analysis of Relapsed/Refractory DLBCL
| PRJNA1200818 | ENA
Methylation profiling DNA methylation of Relapsed/Refractory AML
2023-12-31 | GSE225239 | GEO